The novel coronavirus disease (COVID-19) pandemic has created a shift in the conduct of healthcare, particularly in the use of digital technology in enabling virtual experiences for both physicians and patients, as suggested by experts in the recently concluded 2020 Virtual Forum of the Asia Pacific Medical Technology Association (APACMed 2020).
Nasopharyngeal and throat swabs have the best clinical sensitivity for the molecular detection of the novel coronavirus disease (COVID-19), especially in its early stages, according to a recent Singapore study. However, the performance of these upper respiratory specimens deteriorates beyond the first week of the disease, or when pneumonic symptoms start to manifest.
A prospective, single-centre cohort study in 50 patients demonstrates the feasibility of bedside neuroimaging with low-magnetic field portable MRI in intensive care settings and reports a 40 percent prevalence of neuronal abnormalities among patients with coronavirus disease 2019 (COVID-19).
An ounce of prevention has proven to be worth a pound of cure in Taiwan, where preventive measures against COVID-19, such as basic mask-wearing and hand-sanitizing, have simultaneously contained COVID-19 and led to a decline in other infectious diseases, as reported in a study.
Patients with COVID-19 who experience an ischaemic stroke may have worse outcomes, including greater stroke severity and mortality risk, than those without COVID-19, findings from the Global COVID-19 Stroke Registry showed.
A 4-week course of amoxicillin-clavulanate in children with protracted bacterial bronchitis (PBB) does not improve cough resolution rates compared with a 2-week course, according to a study from Australia. However, the longer course may significantly extend time to first cough exacerbation.
Application for Sputnik V, the tradename of the world’s first registered COVID-19 vaccine, has been submitted to the WHO for accelerated registration via the Emergency Use Listing (EUL) and prequalification.